NEW YORK--(BUSINESS WIRE)--Schrödinger today reported financial results for the second quarter of 2021 and provided a company update.
Schrodinger (SDGR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The four mid-cap stocks discussed here are slated to release earnings results this week. These are CACI, SDGR, AVT and GRWG.
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will report second quarter 2021 financial results on August 12, 2021.
Schrodinger (SDGR) has been struggling lately, but the selling pressure may be coming to an end soon.
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will host its first annual Educator's Day and "Teaching with Schrödinger" Program.
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will present at two investor conferences in July.

Schrodinger: Competitive Advantages Galore

12:10pm, Wednesday, 07'th Jul 2021
Schrodinger is a computational, physics-based molecule discovery platform that is looking to improve human health and quality of life. They are trying to do this by optimizing and transforming the way

The 1 Stock I'd Buy Right Now

05:49am, Saturday, 03'rd Jul 2021
I'm confident that Schrodinger will be a 10-bagger over the next decade. And it might go up a lot more than that.

My Favorite Biotech Stock Right Now

12:00pm, Sunday, 27'th Jun 2021
I'm an owner of Schrodinger because this company's software is revolutionizing drug discovery, and it's going to be a monster stock over the next decade.
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).
Searching for stocks to buy that could legitimately double before 2022? These seven are in position to do just that.
These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies. The post 5 Healthcare Stocks to Buy for Their Game-Changing Potential
Drug Discovery has historically been the most expensive and lengthy step in creating new drugs. SDGR's physics-based software cuts the time in half as well as the costs. Along with being a software co
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will present at two investor conferences in June.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE